The Pulmonary Injury and Repair Center at the University of Alabama at Birmingham has produced a major return on investment in its six years of existence. The Center, begun in 2008 with an initial investment of $140,000 from the UAB School of Medicine, Department of Anesthesiology and Southern Research Institute, has since received nearly $10 million in research funding from government and industry sources.
Those funds have spurred scientific research, recruited new faculty and produced new knowledge in treating lung injury, especially from chemical agents such as chlorine, ammonia and bromine.
Chlorine, ammonia and bromine are commonly used in various industrial applications and are routinely shipped across the country. Exposure to these agents could come as a result of a deliberate terror attack or from an inadvertent leak from a transportation mishap.
“Inhalation of these gases can cause extreme, possibly fatal injury to the lungs,” said Sadis Matalon, Ph.D., distinguished professor and vice chair for research in the Department of Anesthesiology, and director of the center. “Our research is geared toward finding countermeasures that could be employed to minimize pulmonary injury in the event of a chlorine, ammonia or bromine release, whatever the cause may be.”
The UAB center is part of the federal government’s CounterACT Program. Funded by the National Institutes of Health, CounterACT is a translational research program aimed at the discovery and/or identification of better therapeutic medical countermeasures and technologies against chemical threat agents. CounterACT was launched following the terror attacks on Sept. 11, 2001, as awareness grew of potential threats from chemical agents.
UAB is one of the few research institutions in the nation involved in countermeasure research against chlorine and ammonia, and it is the only site looking for agents that would be effective against bromine, according to Matalon.
“We are investigating multiple strategies to respond to lung injury in the event of exposure to these agents,” Matalon said. “We have identified compounds that in preliminary studies have been shown to prevent death after chlorine exposure, for example. Compounds such as antioxidants and nitrites also have promise in reducing or reversing the toxic effects of these agents.”
Matalon says one of the center’s strengths is its reach across the breadth of UAB. Investigators involved in the major projects come from multiple disciplines and include Victor Darley-Usmar, Ph.D., and Jianhua Zhang, Ph.D., pathology; Tim Ness, M.D., anesthesiology; Chad Steele, Ph.D., and Veena Antony, M.D., pulmonary medicine; Rakesh Patel, Ph.D., molecular and cellular pathology; Mohammad Athar, dermatology; and Anupam Agarwal, M.D., nephrology. Other prominent investigators include Edward Postlethwait, Ph.D., Michelle Fanucchi, Ph.D., and Giuseppe Squadrito, Ph.D., in the School of Public Health; as well as James and Diana Noah, Ph.D.s, with Southern Research Institute.
Matalon and Darley-Usmar received a grant to test the role of mitochondrial injury in the initiation and propagation of chlorine injury to the lungs. Matalon is also collaborating with Sven Eric Jordt, Ph.D., of Yale University, to test the effectiveness of a new class of anti-inflammatory agents to decrease chlorine injury.
Patel was recently funded by the CounterACT Program to test the efficacy of nitrites to decrease mortality and lung injury in chlorine-exposed animals. Athar is funded by CounterACT to develop therapeutic interventions of lewisite-mediated injury to the skin, which could contribute to lung injury. Ness was also funded to investigate whether local anesthetics administered post-exposure reduce pain.
“This is a critical issue because people who experience pain have decreased ability to walk away from the epicenter of a chemical attack,” Matalon said.
The center also played a role in the recruitment of prominent new faculty to UAB, says Matalon, including Victor Thannickal, M.D., chair of the Division of Pulmonary, Allergy and Critical Care Medicine, and Jean-Francois Pittet, M.D., professor of anesthesiology.
“The Pulmonary Injury and Repair Center has enhanced collaborations among basic and clinical investigators at UAB and has driven translational research in lung injury and repair,” Matalon said. “It has also strengthened existing interactions among researchers from UAB and Southern Research Institute. These interactions continue to improve our ability to attract new faculty interested in pulmonary research at UAB and to compete for extramural awards.”
Study finds parents’ perceptions play key role in teens’ driving preparednessOverall, parents believe their teens are safer than other drivers.posted 2 days ago 295 viewsThis weekend’s TEDxBirmingham will have UAB flavorBevan, Locke, Saag are among 12 speakers who will speak at the annual, independently organized event which will challenge attendees to embrace the event’s theme of possibility.
Genetic clues to kidney disease uncoveredUAB assays enabled the first genomewide association study of IgA1 O-glycosylation aberrancy in IgA nephropathy, a disease that frequently causes kidney failure.posted 10 days ago 1603 viewsUAB professor uses latest virtual reality technology to improve access to pedestrian safety educationA new mobile virtual reality system helps children learn to cross streets safely.posted 10 days ago 1176 viewsNew braces clinical trial sheds metal bracketsInflatable braces? A new clinical trial at the UAB School of Dentistry is hoping to make metal braces a thing of the past.posted 11 days ago 4110 viewsNew UAB undergraduate degree programs in genetics, genomic sciences and immunology now enrollingTwo new undergraduate programs — genetics and genomic sciences and immunology — are interdepartmental majors in the College of Arts and Sciences and School of Medicine.posted 12 days ago 3601 viewsStopping Alzheimer’s disease: Local research study featured in NewsweekUAB is a clinical site for the A4 Study of Alzheimer’s disease, recently featured in Newsweek magazine.posted 12 days ago 2834 viewsWallace, named first medical director of Telehealth, eyes statewide networkThe new UAB Medicine Telehealth team of Bart Kelly and Eric Wallace aim to steadily grow telehealth providers across the UAB health care spectrum “one program at a time.”posted 12 days ago 1894 viewsSchool of Dentistry ranks first in NIDCR funding for fifth straight yearUAB’s School of Dentistry has ranked first in NIDCR funding since 2012.posted 13 days ago 2467 viewsCastration-resistant prostate cancer cell growth impeded by EndostatinFailure of hormone deprivation therapy used to slow prostate cancer in patients leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options. Endostatin, used in combination therapy, may help delay onset of castration-resistant disease.posted 16 days ago 1800 viewsSickle cell gene linked to elevated risk of kidney failure in UAB studyNew data from the REGARDS study show that blacks with the sickle cell trait are more likely to develop kidney failure requiring dialysis.posted 17 days ago 1352 viewsNominate UAB alumni for Excellence in BusinessThe National Alumni Society’s Top 25 program celebrates the success of Blazer-led companies.posted 18 days ago 674 viewsUAB to launch statewide genetics initiative for better health for all Alabama residentsUAB launches the Alabama Genomic Health Initiative, a statewide effort to use the power of genomics to improve health in Alabama.posted 17 days ago 3740 viewsUAB to provide paid leave benefits for organ donorsUAB employees who are living donors for solid organ or bone-marrow transplants may qualify for as many as four weeks paid leave, effective March 1.posted 25 days ago 1336 viewsHigh school students put cybersecurity skills to the test to win $20,000 in UAB scholarship fundsThe Blazer42 Capture the Flag Scholarship Competition provides valuable experience to high school students in an effort to inspire more to pursue careers in cybersecurity.posted 25 days ago 3080 viewsActivated T-cells drive post-heart attack heart failureThe findings suggest targeting specific T-cell subsets may be a therapeutic approach to prevent heart failure after a heart attack.posted 27 days ago 2328 viewsPreserving vision for astronautsAs NASA prepares for its journey to Mars, one UAB researcher is investigating why so many astronauts suffer from poorer vision after they return to Earth.posted 26 days ago 1659 viewsUAB Biomedical Engineering department ranks fourth in NIH fundingThe department now has 20 full-time faculty members who brought in $4.3 million in funding in 2016.posted a while back 4238 viewsHIV-positive kidney failure patients face greater hurdles in receiving necessary transplantsStudy shows HIV-positive kidney failure patients were 28 percent less likely to receive a transplant compared with their HIV-negative counterparts from 2001-2012.posted a while back 3034 viewsWhite House strategist to lead UAB’s Personalized Medicine InstituteMatt Might, Ph.D., a strategic leader in the White House Precision Medicine Initiative, has been named the inaugural director of the Hugh Kaul Personalized Medicine Institute at UAB.posted a while back 2444 views
- Event Date March 25